MONTELUKAST
SANIS HEALTH INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is MONTELUKAST discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that MONTELUKAST 4MG has been permanently discontinued (last updated April 20, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is MONTELUKAST not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
RATIO-MONTELUKAST
TEVA CANADA LIMITED
DOM-MONTELUKAST
DOMINION PHARMACAL
Other Products
SINGULAIR
ORGANON CANADA INC.
BIO-MONTELUKAST
BIOMED PHARMA
MAR-MONTELUKAST
MARCAN PHARMACEUTICALS INC
MINT-MONTELUKAST
MINT PHARMACEUTICALS INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
JAMP-MONTELUKAST 10mg
JAMP-MONTELUKAST 10mg: may contain foreign fragments of pink candesartan tablets
Moderate health risk
Possible match — not confirmed
PMS-Montelukast
PMS-Montelukast: An impurity is out of trend
Moderate health risk
Possible match — not confirmed
MONTELUKAST
Impurity - Pro Doc MONTELUKAST SODIUM 5mg
Moderate health risk
Possible match — not confirmed
PMS-Montelukast
PMS-Montelukast: impurity
Moderate health risk
Possible match — not confirmed
DIN
02379317
Strength
4MG
Dosage Form
TABLET (CHEWABLE)
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Other Products from SANIS HEALTH INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02286254
400MG · DIN 02286262
100MG · DIN 02286246
400MG · DIN 02286564
70MG · DIN 02352966
10MG · DIN 02519844
12.5MG · DIN 02466821
0.50MG · DIN 02349205
0.25MG · DIN 02349191
200MG · DIN 02364336
10MG · DIN 02331292
5MG · DIN 02331284